Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens

Enterotoxaemia is one of the hazardous diseases of the livestock. In Pakistan prophylaxis failure is due to the vaccination with type D monovalent vaccine. There is a need to develop a cost effective multivalent vaccine against enterotoxaemia using characterized toxinotypes isolated from field. Indi...

Full description

Bibliographic Details
Main Authors: Madeeha TARIQ, Aftab Ahmad ANJUM, Ali Ahmad SHEIKH, Ali Raza AWAN, Muhammad Asad ALI, Mian Muhammad Khubaib SATTAR, Shahid HUSSAIN, Tehreem ALI
Format: Article
Language:English
Published: Kafkas University, Faculty of Veterinary Medicine 2021-07-01
Series:Kafkas Universitesi Veteriner Fakültesi Dergisi
Subjects:
Online Access:http://vetdergikafkas.org/uploads/pdf/pdf_KVFD_2813.pdf
_version_ 1797723525456330752
author Madeeha TARIQ
Aftab Ahmad ANJUM
Ali Ahmad SHEIKH
Ali Raza AWAN
Muhammad Asad ALI
Mian Muhammad Khubaib SATTAR
Shahid HUSSAIN
Tehreem ALI
author_facet Madeeha TARIQ
Aftab Ahmad ANJUM
Ali Ahmad SHEIKH
Ali Raza AWAN
Muhammad Asad ALI
Mian Muhammad Khubaib SATTAR
Shahid HUSSAIN
Tehreem ALI
author_sort Madeeha TARIQ
collection DOAJ
description Enterotoxaemia is one of the hazardous diseases of the livestock. In Pakistan prophylaxis failure is due to the vaccination with type D monovalent vaccine. There is a need to develop a cost effective multivalent vaccine against enterotoxaemia using characterized toxinotypes isolated from field. Indigenously (Punjab, Pakistan) characterized Clostridium perfringens toxinotypes A (MW551947.1), B (MW332247.1) and D (MW332258.1) (n=1 each) were used. These toxinotypes were used to produce higher amount of alpha, beta and epsilon toxin units under culture conditions. Colony forming units (CFU) of each bacterium was determined through the standard plate count method and 106 CFU/mL bacteria were used for vaccine dose. Monovalent, bivalent and multivalent oil adjuvant and alum precipitate vaccines were prepared. Formulated vaccines were passed the stability, sterility and safety test. Bacterin plus toxoid oil adjuvant vaccine produced higher (868.25±3.54 IU/mL) antibody titer at 28th day post vaccination in rabbits and 100% protection was observed after challenge. Multivalent bacterin plus toxoid oil adjuvant vaccine was used in field trials. Increased antibody response was detected after 4 months in sheep (1294.81±1.90 IU/mL) and goats (1091.85±2.51 IU/mL). During the experimental and field trials commercial vaccine did not produced higher antibody titer. Multivalent bacterin plus toxoid oil adjuvant vaccine proved as an excellent candidate for vaccination of animals against C. perfringens diseases, and it produced specific and efficient immune response to be used in field.
first_indexed 2024-03-12T10:03:01Z
format Article
id doaj.art-0bdc9262dfa845a5bd646b494c3fda32
institution Directory Open Access Journal
issn 1300-6045
1309-2251
language English
last_indexed 2024-03-12T10:03:01Z
publishDate 2021-07-01
publisher Kafkas University, Faculty of Veterinary Medicine
record_format Article
series Kafkas Universitesi Veteriner Fakültesi Dergisi
spelling doaj.art-0bdc9262dfa845a5bd646b494c3fda322023-09-02T11:26:24ZengKafkas University, Faculty of Veterinary MedicineKafkas Universitesi Veteriner Fakültesi Dergisi1300-60451309-22512021-07-0127447548210.9775/kvfd.2020.25732Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringensMadeeha TARIQ0https://orcid.org/0000-0001-5235-9419Aftab Ahmad ANJUM1https://orcid.org/0000-0001-8262-8720Ali Ahmad SHEIKH2https://orcid.org/0000-0001-8422-5650Ali Raza AWAN3https://orcid.org/0000-0002-4529-6998Muhammad Asad ALI4https://orcid.org/0000-0003-4038-7054Mian Muhammad Khubaib SATTAR5https://orcid.org/0000-0001-7298-1643Shahid HUSSAIN6https://orcid.org/0000-0001-5138-2051Tehreem ALI7https://orcid.org/0000-0003-0037-3061 Institute of Microbiology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTAN Institute of Microbiology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTANInstitute of Microbiology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTAN Institute of Biochemistry and Biotechnology, Faculty of Biosciences, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTANInstitute of Microbiology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTANDepartment of Microbiology, Faculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur, 63100, PAKISTANVaccine Production Section, INTERVAC (PVT) LTD, 18km Lahore Sheikhupura Road, Sheikhupura, PAKISTANInstitute of Microbiology, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54000, Lahore, PAKISTANEnterotoxaemia is one of the hazardous diseases of the livestock. In Pakistan prophylaxis failure is due to the vaccination with type D monovalent vaccine. There is a need to develop a cost effective multivalent vaccine against enterotoxaemia using characterized toxinotypes isolated from field. Indigenously (Punjab, Pakistan) characterized Clostridium perfringens toxinotypes A (MW551947.1), B (MW332247.1) and D (MW332258.1) (n=1 each) were used. These toxinotypes were used to produce higher amount of alpha, beta and epsilon toxin units under culture conditions. Colony forming units (CFU) of each bacterium was determined through the standard plate count method and 106 CFU/mL bacteria were used for vaccine dose. Monovalent, bivalent and multivalent oil adjuvant and alum precipitate vaccines were prepared. Formulated vaccines were passed the stability, sterility and safety test. Bacterin plus toxoid oil adjuvant vaccine produced higher (868.25±3.54 IU/mL) antibody titer at 28th day post vaccination in rabbits and 100% protection was observed after challenge. Multivalent bacterin plus toxoid oil adjuvant vaccine was used in field trials. Increased antibody response was detected after 4 months in sheep (1294.81±1.90 IU/mL) and goats (1091.85±2.51 IU/mL). During the experimental and field trials commercial vaccine did not produced higher antibody titer. Multivalent bacterin plus toxoid oil adjuvant vaccine proved as an excellent candidate for vaccination of animals against C. perfringens diseases, and it produced specific and efficient immune response to be used in field.http://vetdergikafkas.org/uploads/pdf/pdf_KVFD_2813.pdfalphabacterinbetaepsilontoxoidvaccine
spellingShingle Madeeha TARIQ
Aftab Ahmad ANJUM
Ali Ahmad SHEIKH
Ali Raza AWAN
Muhammad Asad ALI
Mian Muhammad Khubaib SATTAR
Shahid HUSSAIN
Tehreem ALI
Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
Kafkas Universitesi Veteriner Fakültesi Dergisi
alpha
bacterin
beta
epsilon
toxoid
vaccine
title Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
title_full Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
title_fullStr Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
title_full_unstemmed Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
title_short Preparation and Evaluation of Alum Precipitate and Oil Adjuvant Multivalent Vaccines Against Clostridium perfringens
title_sort preparation and evaluation of alum precipitate and oil adjuvant multivalent vaccines against clostridium perfringens
topic alpha
bacterin
beta
epsilon
toxoid
vaccine
url http://vetdergikafkas.org/uploads/pdf/pdf_KVFD_2813.pdf
work_keys_str_mv AT madeehatariq preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT aftabahmadanjum preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT aliahmadsheikh preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT alirazaawan preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT muhammadasadali preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT mianmuhammadkhubaibsattar preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT shahidhussain preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens
AT tehreemali preparationandevaluationofalumprecipitateandoiladjuvantmultivalentvaccinesagainstclostridiumperfringens